Dupilumab ef cacy and safety in patients with moderate to severe asthma: a systematic review and meta-analysis

HIGHLIGHTS

  • who: . et al. from the Helwan University, University of Naples Federico II, Italy have published the research work: Dupilumab ef cacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis, in the Journal: (JOURNAL)
  • what: In this systematic review and meta-analysis, the authors aimed to solve this contrast by evaluating the safety and efficacy of dupilumab in patients with moderate to severe asthma.
  • how: Heterogeneity among the studies was examined using Cochrane`s p values and I2. The results were consistent with these mechanisms.
 

Logo ScioWire Beta black

If you want to have access to all the content you need to log in!

Thanks :)

If you don't have an account, you can create one here.

 

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?